Neuren Pharmaceuticals Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.02 |
Market Cap |
$84.6 M |
Shares Outstanding |
100.67 M |
Public Float |
- |
Neuren Pharmaceuticals Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.03 |
Market Cap |
AUD121.23 M |
Shares Outstanding |
103.17 M |
Public Float |
63.07 M |
Address |
697 Burke Road Camberwell Victoria (VIC) 3124 Australia |
Employees | - |
Website | http://www.neurenpharma.com |
Updated | 07/08/2019 |
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment and neurodegenerative disorders. The company was founded on December 17, 2001 and is headquartered in Melbourne, Australia. . |